HR-Positive Metastatic Breast Cancer — A Discussion and Debate on First- and Second-Line Therapy

About this episode

Dr. Sara A Hurvitz and Dr. Virginia Kaklamani discuss the management of ER-positive, HER2-negative metastatic breast cancer.

Dr Sara A Hurvitz from the Fred Hutchinson Cancer Center in Seattle, Washington, and Dr Virginia Kaklamani from the UT Health San Antonio MD Anderson Cancer Center in San Antonio, Texas, discuss patient cases and review relevant data on the management of ER-positive, HER2-negative metastatic breast cancer. CME information and select publications

People in this episode

Host: Dr. Neil Love

Guests: Dr Sara A Hurvitz, Dr Virginia Kaklamani

Topics covered

• metastatic breast cancer
• ER-positive
• HER2-negative
• first-line therapy
• second-line therapy
• patient management

Keywords

• breast cancer
• metastatic
• ER-positive
• HER2-negative
• therapy
• patient cases
• CME

Mentioned in this episode

Organizations: Fred Hutchinson Cancer Center, UT Health San Antonio MD Anderson Cancer Center

Places: Seattle, Washington, San Antonio, Texas

More episodes of Breast Cancer Update

• Desmoid Tumors — Microlearning Activity 3 with Prof Bernd Kasper · June 2, 2026 · 23 min
• Oral SERDs for Breast Cancer — Year in Review Series on Relevant New Datasets and Advances · April 30, 2026 · 57 min
• HR-Positive Metastatic Breast Cancer — An Interview with Dr Seth Wander on Optimizing Biomarker Assessment and Related Treatment Decision-Making · April 16, 2026 · 1h 0m
• ER-Positive, HER2-Positive Metastatic Breast Cancer — What Clinicians Want to Know About First-Line and Maintenance Therapy · April 14, 2026 · 58 min
• Desmoid Tumors — Microlearning Activity 2 with Dr Ravin Ratan · April 7, 2026 · 28 min
• Diabetology in Breast Cancer — Managing Hyperglycemia in Patients with Breast Cancer Receiving Agents Targeting the PI3K/AKT/PTEN Pathway · March 30, 2026 · 1h 16m